Cargando…

Enhanced nuclear localization of YAP1‐2 contributes to EGF‐induced EMT in NSCLC

YAP1, a key mediator of the Hippo pathway, plays an important role in tumorigenesis. Alternative splicing of human YAP1 mRNA results in two major isoforms: YAP1‐1, which contains a single WW domain, and YAP1‐2, which contains two WW domains, respectively. We here investigated the functions and the u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Qiang, Quan, Mei‐Yu, Xu, Le, Cai, Yaxin, Cai, Jue‐Ting, Li, Xue, Feng, Guifeng, Chen, Aiping, Yang, Weiwei, Dhlamini, Qhaweni, Jiang, Tian‐Fang, Shen, Chengguo, Chen, Chengshui, Zhang, Jin‐San
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831977/ https://www.ncbi.nlm.nih.gov/pubmed/35014181 http://dx.doi.org/10.1111/jcmm.17150

Ejemplares similares

FGF10 and Lipofibroblasts in Lung Homeostasis and Disease: Insights Gained From the Adipocytes
por: Lv, Yu-Qing, et al.
Publicado: (2021)

FGF1 alleviates LPS-induced acute lung injury via suppression of inflammation and oxidative stress
por: Dhlamini, Qhaweni, et al.
Publicado: (2022)

YAP modulates TGF-β1-induced simultaneous apoptosis and EMT through upregulation of the EGF receptor
por: Liu, Yi, et al.
Publicado: (2017)

Yap1-2 Isoform Is the Primary Mediator in TGF-β1 Induced EMT in Pancreatic Cancer
por: Gao, Chao, et al.
Publicado: (2021)

FGF10 Therapeutic Administration Promotes Mobilization of Injury-Activated Alveolar Progenitors in a Mouse Fibrosis Model
por: Lv, Yu-Qing, et al.
Publicado: (2022)

Repression of YAP by NCTD disrupts NSCLC progression
por: Guo, Jiwei, et al.
Publicado: (2016)

TACC3 Is Essential for EGF-Mediated EMT in Cervical Cancer
por: Ha, Geun-Hyoung, et al.
Publicado: (2013)

Correction: TACC3 Is Essential for EGF-Mediated EMT in Cervical Cancer
por: Ha, Geun-Hyoung, et al.
Publicado: (2013)

Correlation between FAK and EGF-Induced EMT in Colorectal Cancer Cells
por: Huang, Kun, et al.
Publicado: (2020)

NSCLC depend upon YAP expression and nuclear localization after acquiring resistance to EGFR inhibitors
por: McGowan, Marc, et al.
Publicado: (2017)

Calreticulin promotes EGF-induced EMT in pancreatic cancer cells via Integrin/EGFR-ERK/MAPK signaling pathway
por: Sheng, Weiwei, et al.
Publicado: (2017)

EGF Receptor Signaling Modulates YAP Activation and Promotes Experimental Proliferative Vitreoretinopathy
por: Zhang, Wei, et al.
Publicado: (2022)

miR-944 Suppresses EGF-Induced EMT in Colorectal Cancer Cells by Directly Targeting GATA6
por: Tang, JingTong, et al.
Publicado: (2021)

Musashi2 promotes EGF-induced EMT in pancreatic cancer via ZEB1-ERK/MAPK signaling
por: Sheng, Weiwei, et al.
Publicado: (2020)

YAP1 contributes to NSCLC invasion and migration by promoting Slug transcription via the transcription co-factor TEAD
por: Yu, Mengxue, et al.
Publicado: (2018)

The antineoplastic drug metformin downregulates YAP by interfering with IRF-1 binding to the YAP promoter in NSCLC
por: Jin, Dan, et al.
Publicado: (2018)

Correction to: Musashi2 promotes EGF-induced EMT in pancreatic cancer via ZEB1-ERK/MAPK signaling
por: Sheng, Weiwei, et al.
Publicado: (2020)

EMT-Mediated Acquired EGFR-TKI Resistance in NSCLC: Mechanisms and Strategies
por: Zhu, Xuan, et al.
Publicado: (2019)

EGF Induces Migration Independent of EMT or Invasion in A549 Lung Adenocarcinoma Cells
por: Schelch, Karin, et al.
Publicado: (2021)

Metformin-repressed miR-381-YAP-snail axis activity disrupts NSCLC growth and metastasis
por: Jin, Dan, et al.
Publicado: (2020)

Correction: Metformin-repressed miR-381-YAP-snail axis activity disrupts NSCLC growth and metastasis
por: Jin, Dan, et al.
Publicado: (2022)

N6-methyladenosine-induced circ1662 promotes metastasis of colorectal cancer by accelerating YAP1 nuclear localization
por: Chen, Chen, et al.
Publicado: (2021)

Development and Evaluation of (18)F-IRS for Molecular Imaging Mutant EGF Receptors in NSCLC
por: Song, Yan, et al.
Publicado: (2017)

Survival of NSCLC Patients Treated with Cimavax-EGF as Switch Maintenance in the Real-World Scenario
por: Flores Vega, Yoanna I., et al.
Publicado: (2023)

YAP-Dependent AXL Overexpression Mediates Resistance to EGFR Inhibitors in NSCLC
por: Ghiso, Elena, et al.
Publicado: (2017)

YAP regulates PD-L1 expression in human NSCLC cells
por: Miao, Jinbai, et al.
Publicado: (2017)

Augmenting antibody response to EGF-depleting immunotherapy: Findings from a phase I trial of CIMAvax-EGF in combination with nivolumab in advanced stage NSCLC
por: Evans, Rachel, et al.
Publicado: (2022)

FHL2 deficiency impairs follicular development and fertility by attenuating EGF/EGFR/YAP signaling in ovarian granulosa cells
por: Wang, Chen, et al.
Publicado: (2023)

MiR-338-5p Inhibits EGF-Induced EMT in Pancreatic Cancer Cells by Targeting EGFR/ERK Signaling
por: Sun, Jian, et al.
Publicado: (2021)

m(6)A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2–mediated YAP activity in NSCLC
por: Jin, Dan, et al.
Publicado: (2020)

Achyranthes bidentata polysaccharide can safely prevent NSCLC metastasis via targeting EGFR and EMT
por: Zhong, Chunlian, et al.
Publicado: (2020)

Nuclear Import and Export of YAP and TAZ
por: Kofler, Michael, et al.
Publicado: (2023)

Correction: m6A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2–mediated YAP activity in NSCLC
por: Jin, Dan, et al.
Publicado: (2022)

Cinnamaldehyde Suppressed EGF-Induced EMT Process and Inhibits Ovarian Cancer Progression Through PI3K/AKT Pathway
por: Wang, Yue, et al.
Publicado: (2022)

Involvement of FoxQ1 in NSCLC through regulating EMT and increasing chemosensitivity
por: Feng, Jian, et al.
Publicado: (2014)

TMEM107 inhibits EMT and invasion of NSCLC through regulating the Hedgehog pathway
por: Xu, Huihui, et al.
Publicado: (2020)

Alectinib and lorlatinib function by modulating EMT-related proteins and MMPs in NSCLC metastasis
por: Feng, Xu, et al.
Publicado: (2021)

UBE2T regulates FANCI monoubiquitination to promote NSCLC progression by activating EMT
por: Zhang, Jiguang, et al.
Publicado: (2022)

PRMT-1 and p120-Catenin as EMT Mediators in Osimertinib Resistance in NSCLC
por: Racherla, Kavya Sri, et al.
Publicado: (2023)

Nuclear translocation and activation of YAP by hypoxia contributes to the chemoresistance of SN38 in hepatocellular carcinoma cells
por: Dai, Xiao-Yang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_sqgp19s580d7mq49t39ikv70e1